Wordt geladen...
Poly (ADP-Ribose) Polymerase Inhibitor, ABT888, Improved Cisplatin Effect in Human Oral Cell Carcinoma
Cisplatin is one of the chemotherapeutic drugs used for the management of oral carcinoma, in which combined therapies are estimated to exert superior therapeutic efficacy compared with monotherapy. It is known that poly(ADP-ribosyl)ation is implicated in a multiplicity of cellular activities, such a...
Bewaard in:
| Gepubliceerd in: | Biomedicines |
|---|---|
| Hoofdauteurs: | , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
MDPI
2021
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8301366/ https://ncbi.nlm.nih.gov/pubmed/34356835 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biomedicines9070771 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|